STOCK TITAN
  1. Home
  2. Sec-filings
  3. GBIO
  4. [EFFECT] Generation Bio Co. SEC Filing

[EFFECT] Generation Bio Co. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 10, 2026
Accession Number: 0001104659-26-012151
Submission Type: POS AM
CIK: 0001733294
Company Name: Generation Bio Co.
File Number: 333-281335

Source: View Original Filing on SEC EDGAR

Stock GBIO logo
Generation Bio Co.

NASDAQ:GBIO

GBIO Rankings

#5768 Ranked by Market Cap
N/A Ranked by Dividends

GBIO Latest News

Jan 29, 2026
Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs
Dec 15, 2025
XOMA Royalty Enters into Agreement to Acquire Generation Bio
Nov 5, 2025
Generation Bio Announces Third Quarter 2025 Financial Results
Oct 29, 2025
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors
Oct 22, 2025
Generation Bio Announces CEO Transition

GBIO Latest SEC Filings

Feb 11, 2026
[SCHEDULE 13G/A] Generation Bio Co. Amended Passive Investment Disclosure
Feb 9, 2026
[Form 4] Generation Bio Co. Insider Trading Activity
Feb 9, 2026
[Form 4] Generation Bio Co. Insider Trading Activity
Feb 9, 2026
[Form 4] Generation Bio Co. Insider Trading Activity
Feb 9, 2026
[Form 4] Generation Bio Co. Insider Trading Activity

GBIO Stock Data

35.98M
5.78M
14.24%
62.31%
2.9%
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE